ENO1 and glioblastoma: Subsequent studies should delve into the signaling cascades mediated by ENO1 that drive M2-TAM polarization, elucidate how these pathways interact with other immune and stromal components within the TIME, and further investigate the cross-regulatory mechanisms between GBM and the TIME to enhance therapeutic efficacy.